Silver lining: reduced relapse with chronic GVHD after transplant for MDS | Aplastic Anemia & MDS International Foundation Return to top.
  1. Education
  2. Research Articles
  3. Silver lining: reduced relapse with chronic GVHD after transplant for MDS

Silver lining: reduced relapse with chronic GVHD after transplant for MDS

Journal Title: 
Clinical Cancer Research: an official Journal of the American Association of Cancer Research
Primary Author: 
Eckel AM
Author(s): 
Eckel AM, Deeg HJ
Original Publication Date: 
Friday, October 16, 2020
Full Article on PubMed: 
https://www.ncbi.nlm.nih.gov/pubmed/33067257/

Chronic graft-versus-host disease (GVHD) following hematopoietic cell transplantation is associated with reduced relapse incidence in patients with leukemias. This impact has been investigated in myelodysplastic syndrome, showing a beneficial impact of limited chronic GVHD on transplant outcomes in a cohort of more than 3,000 patients.

Bone Marrow Disease(s): 
  • graft versus host disease (GVHD)
  • myelodysplastic syndromes (MDS)
Share with addtoany.com.